PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients
Condition(s):Hematologic DiseasesLast Updated:April 16, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Hematologic DiseasesLast Updated:April 16, 2020Unknown status
Condition(s):Lymphoma, Non-Hodgkin; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Small-Cell; Waldenstrom Macroglobulinemia; Lymphoma, B-Cell, Marginal ZoneLast Updated:February 9, 2023Completed
Condition(s):Soft Tissue Sarcoma; Lymphoma; Leukemia; Wilms’ Tumor; OsteosarcomaLast Updated:October 31, 2018Completed
Condition(s):Acute Lymphoblastic Leukemia (ALL)Last Updated:September 9, 2021Terminated
Condition(s):Malignant MelanomaLast Updated:December 12, 2019Completed
Condition(s):Acute Leukemias of Ambiguous Lineage; Acute Undifferentiated Leukemia; Angioimmunoblastic T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Relapsing Chronic Myelogenous Leukemia; Small Intestine Lymphoma; Unspecified Childhood Solid Tumor, Protocol SpecificLast Updated:May 1, 2014Terminated
Condition(s):HemangiomaLast Updated:June 11, 2013Terminated
Condition(s):RHABDOMYOSARCOMALast Updated:September 18, 2019Completed
Condition(s):B-cell Acute Lymphoblastic LeukemiaLast Updated:March 2, 2022Withdrawn
Condition(s):AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Small Noncleaved Cell LymphomaLast Updated:January 25, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.